Surgical management of primary hyperparathyroidixsm

Area of Science:

• Endocrinology
• Surgical Oncology
• Nuclear Medicine

Background:

• Bilateral neck exploration for primary hyperparathyroidism is highly effective but efforts continue to minimize invasiveness.
• Advancements in preoperative localization and intraoperative monitoring aim to improve surgical outcomes and patient experience.

Purpose of the Study:

• To evaluate the efficacy and safety of minimally invasive parathyroidectomy guided by sestamibi scintigraphy and intraoperative parathyroid hormone (PTH) assay.
• To explore innovations in parathyroidectomy, including unilateral approaches and endoscopic techniques.

Main Methods:

• Utilized sestamibi scintigraphy for preoperative localization of parathyroid adenomas.
• Employed intraoperative quick PTH assay to confirm successful adenoma removal.
• Compared outcomes of minimally invasive unilateral exploration with traditional bilateral exploration.

Main Results:

• Sestamibi scintigraphy significantly improved adenoma localization accuracy, enabling feasible unilateral neck exploration.
• Sestamibi-guided parathyroidectomy resulted in shorter procedure times, smaller incisions, fewer complications, and reduced narcotic use.
• Intraoperative quick PTH assay accurately predicted procedural success and improved outcomes in both initial and reoperative cases.

Conclusions:

• Minimally invasive parathyroidectomy, particularly unilateral approaches guided by sestamibi scanning and intraoperative PTH monitoring, offers a safe and effective treatment for primary hyperparathyroidism.
• These techniques enhance surgical efficiency, reduce patient morbidity, and maintain high cure rates.
• Further innovation in endoscopic parathyroidectomy techniques holds promise for continued advancements in minimally invasive endocrine surgery.